31 / 64
Coprimary
Secondary
PD‐L1+ n=362
ITT, n=915
Sunitinib
N=184
Atezo/beva
N=178
Sunitinib
N=461
Atezo/beva
N=454
mPFS, mo
7.7
11.2
8.4
11.2
95% CI
6.8, 9.7
8.9, 15
7.5, 9.7
9.6, 13.3
Stratified HR
0 74
0 83
.
(0.57, 0.96)
.
(0.70, 0.97)
ORR %
35
43
33
37
Motzer R. ASCO‐GU 2018 #578